The Global Alliance for Musculoskeletal Health is a network of national and international patient, professional and scientific organisations working to prevent and improve treatments for musculoskeletal conditions.
It is a multi-disciplinary, global organisation aiming to improve health policy and practice through its unified voice and global reach. It has a network of people and organisations promoting initiatives in all parts of the world.
Its home office is located within the Department of Rheumatology, Institute of Bone & Joint Research.
Our vision is a society where prevention, treatment and care for people with musculoskeletal disorders is of a high standard and consistently accessible, giving people the freedom to move without pain and independently.
Our objective is to raise awareness of the importance of musculoskeletal conditions at a global, regional and national level.
The Global Alliance for Musculoskeletal Health is calling for governments, health policy makers and the World Health Organisation to prioritise the prevention and treatment of musculoskeletal conditions and injuries. It would like to see the following issues addressed:
- Promotion of a lifestyle that will optimise musculoskeletal health at all ages
- Prevention of musculoskeletal disorders and injuries
- Identification and treatment for those at highest risk
- Accessible, timely, safe, appropriate treatment to control symptoms and prevent unnecessary disability
- Accessible and appropriate rehabilitation to reduce any disability, including self-management
- Equity for all sectors of society
- Support for people to be economically independent
- Research and education to advance knowledge and care
Lead
People
Network
Projects
Publications
Professor Lyn March AM
Project Lead and Coordinating Principal Investigator
Australian Arthritis and Autoimmune Biobank Collaborative (Uni Syd)
Liggins Professor of Rheumatology & Musculoskeletal Epidemiology
Institute of Bone and Joint Research, Kolling Institute
Head of Department
Department of Rheumatology, Royal North Shore Hospital
Lyn is the Head of Rheumatology at Sydney’s Royal North Shore Hospital and Liggins Professor of Rheumatology and Musculoskeletal Epidemiology at Sydney University.
Lyn graduated from medicine with first class honours from the University of Sydney, then went on to gain a PhD from Sydney and a MSc from the London School of Hygiene and Tropical Medicine. She has been an active clinician and researcher for more than 25 years. She was made a Member of the Order of Australia for her significant services in the areas of rheumatology and clinical epidemiology as an academic, researcher and clinician. She led the international expert group that generated the latest global burden of musculoskeletal disease data. Lyn is an executive member of OMERACT the international group standardising patient reported outcome measures in rheumatology, on the Executive Committee for the Global Alliance for MSK Health, Co-lead of their Surveillance Task Force and member of their WHO working party. Lyn advocates to raise the profile of musculoskeletal conditions and to improve evidence-based patient care through policy development and translational and discovery research. She co-led the NSW Health Agency for Clinical Innovation’s MSK Network during the development of the MSK Models of Care now part of Leading Better Value Care. Her latest challenge is the establishment of the A3BC – a national collaboration linking the patient outcomes registry ARAD with a new biospecimens network to deliver precision medicine to the individual patient and build a national research resource working to find a cure for arthritis and autoimmune rheumatic conditions.
Dr Marita Cross
Postdoctoral Research Associate, Northern Clinical School
Dr Damian Hoy
Co-leader Global Musculoskeletal Surveillance Taskforce
